PARP inhibitors are recently developed drugs that have shown great promise against some types of ovarian, breast, prostate and pancreatic cancer, but many patients' tumors develop resistance to the drugs. Now researchers ...
Cell & Microbiology
Jan 19, 2021
0
24
Pancreatic cancer has one of the worst survival rates among cancers. Patients can expect as low as a 9% chance to live for at least five years after being diagnosed.
Bio & Medicine
Feb 14, 2020
0
518
Mitochondria burn oxygen and provide energy for the body. Cells lacking oxygen or nutrients have to change their energy supply quickly in order to keep growing. Scientists from the Max Planck Institute for Biology of Ageing ...
Cell & Microbiology
Nov 7, 2019
0
359
A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease. In the U.S. this year, some 53,000 new cases will be diagnosed, and 42,000 patients will die ...
Bio & Medicine
Oct 19, 2016
0
18
A major reason why cancer drugs fail is that they cannot penetrate the high-pressure environment of solid tumors. A study published May 10th in Biophysical Journal reveals that a large, naturally occurring molecule called ...
Biochemistry
May 10, 2016
0
18
A nanoparticle drug-delivery system that combines two complementary types of anticancer treatment could improve outcomes for patients with pancreatic cancer and other highly treatment-resistant tumors while decreasing toxicity. ...
Bio & Medicine
Jan 19, 2016
0
37
Scientists at UCLA's California NanoSystems Institute and Jonsson Comprehensive Cancer Center have combined their nanotechnology expertise to create a new treatment that may solve some of the problems of using chemotherapy ...
Bio & Medicine
Mar 24, 2015
0
390
A new method of microscopic drug delivery that could greatly improve the treatment of deadly pancreatic cancer has been proven to work in mice at UCLA's Jonsson Comprehensive Cancer Center.
Bio & Medicine
Nov 14, 2013
0
0
A "vicious cycle" produces mucus that protects uterine and pancreatic cancer cells and promotes their proliferation, according to researchers at Rice University. The researchers offer hope for a therapeutic solution.
Biochemistry
Sep 16, 2013
0
0
(Phys.org)—The medical community is armed with new insights and new options for drug design and discovery to treat fatal diseases such as pancreatic cancer. Using in silico computational tools to complement the results ...
Bio & Medicine
Oct 10, 2012
0
0
